Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose lithium pilot study in familial adenomatous polyposis
NL-OMON51473Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lithium in Colonic Adenomatous Polyposis, sponsored by Amsterdam University Medical Center. Primary endpoint: Clone size in intestinal crypts by NOTUM staining. Started Jun 2022; status: completed.
02
Drugs
lithium
03
Conditions
Colonic Adenomatous Polyposis
Beyond the preview
Go deeper on NL-OMON51473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51473.